Nanotherapy for Duchenne muscular dystrophy.

about

Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.

P2860

Q52564618-80FBBB34-290F-473E-BE21-00E3164F74BD

P2860

Nanotherapy for Duchenne muscular dystrophy.

Item

http://www.wikidata.org/entity/Q39233936

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Nanotherapy for Duchenne muscular dystrophy.

@en

Nanotherapy for Duchenne muscular dystrophy.

@nl

type

Item

label

Nanotherapy for Duchenne muscular dystrophy.

@en

Nanotherapy for Duchenne muscular dystrophy.

@nl

altLabel

Nanotherapy for Duchenne muscular dystrophy

@en

prefLabel

Nanotherapy for Duchenne muscular dystrophy.

@en

Nanotherapy for Duchenne muscular dystrophy.

@nl

P1476

Nanotherapy for Duchenne muscular dystrophy.

@en

P2093

Chady H Hakim

http://www.w3.org/2001/XMLSchema#string

Michael E Nance

http://www.w3.org/2001/XMLSchema#string

N Nora Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Parvovirus glycan interactions

Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

Development and applications of CRISPR-Cas9 for genome engineering.

A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner

P304

e1472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/WNAN.1472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dongsheng Duan

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28398005

http://www.w3.org/2001/XMLSchema#string

P932

5636659

http://www.w3.org/2001/XMLSchema#string

Nanotherapy for Duchenne muscular dystrophy.

about

P2860

P2860

Nanotherapy for Duchenne muscular dystrophy.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932